Glycoprotein IIb/IIIa Inhibitors

The following sections are included:

• Introduction

  • Platelet aggregation in acute coronary syndromes and percutaneous coronary intervention

  • Glycoprotein IIb/IIIa in platelet physiology

  • Heterogeneity in clinical trial data

• Abciximab

  • Abciximab in unstable angina and percutaneous coronary intervention

  • Abciximab in ST segment elevation myocardial infarction

• Small Molecule GP IIb/IIIa Inhibitors

• Oral GP IIb/IIIa Inhibitors

• New Trials of GP IIb/IIIa Inhibitors

• Summary/Conclusions

• Summary Box

• References